BIOTECH TARGET N V - 19 Jan 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: 10%+ Owner
Signature: /s/Ivo Betschart
Issuer symbol: MGNX
Transactions as of: 19 Jan 2023
Net transactions value: +$794,925
Form type: 4
Filing time: 23 Jan 2023, 15:21:43 UTC
Previous filing: 28 Dec 2022
Next filing: 16 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Purchase	$794,925	+150,000	+1.7%	$5.30	9,079,963	19 Jan 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of MacroGenics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.